The article discusses the history of the diagnosis of myocardial infarction and its biomarkers, CK-MB and troponin. It describes research developments related to the pathogenesis of coronary artery disease and the diagnosis of myocardial infarction. It also explores the efficiency of the creatine kinase-MB (CK-MB) isoenzyme for the diagnosis and quantitative assessment of the disease.